Correlation Between Dogwood Therapeutics, and Viracta Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dogwood Therapeutics, and Viracta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dogwood Therapeutics, and Viracta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dogwood Therapeutics, and Viracta Therapeutics, you can compare the effects of market volatilities on Dogwood Therapeutics, and Viracta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dogwood Therapeutics, with a short position of Viracta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dogwood Therapeutics, and Viracta Therapeutics.
Diversification Opportunities for Dogwood Therapeutics, and Viracta Therapeutics
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Dogwood and Viracta is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Dogwood Therapeutics, and Viracta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viracta Therapeutics and Dogwood Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dogwood Therapeutics, are associated (or correlated) with Viracta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viracta Therapeutics has no effect on the direction of Dogwood Therapeutics, i.e., Dogwood Therapeutics, and Viracta Therapeutics go up and down completely randomly.
Pair Corralation between Dogwood Therapeutics, and Viracta Therapeutics
Given the investment horizon of 90 days Dogwood Therapeutics, is expected to generate 2.86 times more return on investment than Viracta Therapeutics. However, Dogwood Therapeutics, is 2.86 times more volatile than Viracta Therapeutics. It trades about -0.08 of its potential returns per unit of risk. Viracta Therapeutics is currently generating about -0.29 per unit of risk. If you would invest 416.00 in Dogwood Therapeutics, on August 31, 2024 and sell it today you would lose (156.00) from holding Dogwood Therapeutics, or give up 37.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dogwood Therapeutics, vs. Viracta Therapeutics
Performance |
| Timeline |
| Dogwood Therapeutics, |
| Viracta Therapeutics |
Dogwood Therapeutics, and Viracta Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dogwood Therapeutics, and Viracta Therapeutics
The main advantage of trading using opposite Dogwood Therapeutics, and Viracta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dogwood Therapeutics, position performs unexpectedly, Viracta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viracta Therapeutics will offset losses from the drop in Viracta Therapeutics' long position.| Dogwood Therapeutics, vs. Viracta Therapeutics | Dogwood Therapeutics, vs. Viking Therapeutics | Dogwood Therapeutics, vs. Dyadic International | Dogwood Therapeutics, vs. Vanda Pharmaceuticals |
| Viracta Therapeutics vs. Vincerx Pharma | Viracta Therapeutics vs. Rallybio Corp | Viracta Therapeutics vs. Tenaya Therapeutics | Viracta Therapeutics vs. Lyra Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |